LGND

SEC source: 0000886163-23-000069 · edgardoc.xml · nonDerivative · entry 1

Zimmermann Martine · CIK 0001994049 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,285

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three substantially equal annual installments on September 22, 2024; September 22, 2025; and September 22, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

SEC source: 0000886163-23-000051 · edgardoc.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · CHIEF LEGAL OFFICER &

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,411

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

SEC source: 0000886163-23-000045 · edgardoc.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · PRESIDENT & CHIEF OPERATING

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 99,124

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

SEC source: 0000886163-23-000044 · edgardoc.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,517

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

SEC source: 0000886163-23-000043 · edgardoc.xml · derivative · entry 2

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,461

Underlying: Common Stock · 5,461 shares

Expires 2033-06-09

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000043 · edgardoc.xml · nonDerivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,567

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000042 · edgardoc.xml · derivative · entry 2

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,461

Underlying: Common Stock · 5,461 shares

Expires 2033-06-09

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000042 · edgardoc.xml · nonDerivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,263

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000041 · edgardoc.xml · derivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,461

Underlying: Common Stock · 5,461 shares

Expires 2033-06-09

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000041 · edgardoc.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,630

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000040 · edgardoc.xml · derivative · entry 4

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,461

Underlying: Common Stock · 5,461 shares

Expires 2033-06-09

F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000040 · edgardoc.xml · nonDerivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,529

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000039 · edgardoc.xml · derivative · entry 2

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,461

Underlying: Common Stock · 5,461 shares

Expires 2033-06-09

F2 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000039 · edgardoc.xml · nonDerivative · entry 1

Haas Jason · CIK 0001883821 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,145

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 9, 2023. Fully vests on the earlier of (A) the date of the next annual meeting of the Company stockholders following the grant date or (B) on the first anniversary of the date of grant.

SEC source: 0000886163-23-000038 · edgardoc.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · CHIEF EXECUTIVE OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 69,090

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

F2 · balance_after: The number reflected in Column 5 reconciles the total number of shares beneficially held following the transactions reported herein.

SEC source: 0001104659-23-073212 · tm2319289-1_4seq1.xml · derivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,461

Underlying: Common Stock · 5,461 shares

Expires 2033-06-09

F2 · security: These securities, as represented in Column 5, were acquired by a grant of 5,461 shares approved by the Board of Directors of the Company at the 2023 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.

F2 · derivative.exercise_date: These securities, as represented in Column 5, were acquired by a grant of 5,461 shares approved by the Board of Directors of the Company at the 2023 Meeting. That grant (a) vests in full on the earlier of (i) the date of the next annual meeting of the Company stockholders following the grant date or (ii) on the first anniversary of the grant date, and (b) will vest immediately (i) upon a change in control or a hostile takeover of the Company or (ii) the death or permanent disability of the grantee if still serving at that time.

SEC source: 0001104659-23-073212 · tm2319289-1_4seq1.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,926

F1 · security: These securities, as represented in Column 5, include a grant of 1,142 restricted share units approved by the Board of Directors of the Company at the 2023 Meeting, which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date.

SEC source: 0000899243-23-013275 · doc4.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,488

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.20 to $77.24. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · balance_after: The number reflected in Column 5 reconciles the total number of shares beneficially held following the transactions reported herein.

SEC source: 0001104659-23-059680 · tm2315666-1_4seq1.xml · derivative · entry 3

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 927

Underlying: Common Stock · 6,408 shares

Expires 2023-06-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · security: These securities, as represented in Column 5, were acquired by a grant of 7,335 shares approved by the Board of Directors of the Company at the 2013 Meeting, as previously reported on the Reporting Persons Form 4 dated 13 June 2013. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time.

F3 · derivative.exercise_date: These securities, as represented in Column 5, were acquired by a grant of 7,335 shares approved by the Board of Directors of the Company at the 2013 Meeting, as previously reported on the Reporting Persons Form 4 dated 13 June 2013. That grant vested in full on the first anniversary of the grant date or immediately (x) upon a change in control or a hostile takeover of the Company or (y) the death or permanent disability of the grantee if still serving at that time.

SEC source: 0001104659-23-059680 · tm2315666-1_4seq1.xml · nonDerivative · entry 2

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,784

F1 · security: These securities, as represented in Column 5, include a grant of 1,723 restricted shares approved by the Board of Directors of the Company at the 2022 Meeting ("2022 Shares"), which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date. As reported on the Reporting Person's Form 4 dated 14 June 2022, which was filed to reflect the 2022 Meeting grant, the original grant was for 1,004 2022 Shares. The reference to 1,732 2022 Shares reflects certain adjustments by the Company to the 2022 Shares following the Company's 1 November 2022 distribution of a legacy business.

F2 · security: The price reported in Column 4 is an average. These shares were sold in separate transactions for the following number of shares and at the respective prices: $77.29 (100), $77.25 (8), $77.23 (41), $77.22 (36), $77.21 (201), $77.20 (372), $77.18 (800), $77.17 (120), $77.16 (34), $77.15 (971), $77.14 (1,305), $77.13 (151), $77.12 (1), $77.11 (239), $77.10 (101), $77.09 (100), $77.08 (1,065), $77.01 (9), and $77.00 (754). This disposition was reported on a Form 144 for filed 10 May 2023.

SEC source: 0001104659-23-059680 · tm2315666-1_4seq1.xml · nonDerivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,192

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: These securities, as represented in Column 5, include a grant of 1,723 restricted shares approved by the Board of Directors of the Company at the 2022 Meeting ("2022 Shares"), which shares will vest in full on the earlier of (a) the date of the next annual meeting of the Company stockholders following the grant date or (b) on the first anniversary of the grant date. As reported on the Reporting Person's Form 4 dated 14 June 2022, which was filed to reflect the 2022 Meeting grant, the original grant was for 1,004 2022 Shares. The reference to 1,732 2022 Shares reflects certain adjustments by the Company to the 2022 Shares following the Company's 1 November 2022 distribution of a legacy business.

SEC source: 0000899243-23-012541 · doc4.xml · derivative · entry 4

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,408 shares

Expires 2023-06-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Acquired by a grant of the Board of Directors of the Company at their annual meeting on June 11, 2013, and will fully vest on the first anniversary of the grant date.

SEC source: 0000899243-23-012541 · doc4.xml · nonDerivative · entry 3

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,213

F2 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.02 to $77.19. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000899243-23-012541 · doc4.xml · nonDerivative · entry 2

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,802

F1 · price: The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $76.00 to $76.965. The Reporting Person undertakes to provide the Registrant, any securityholder of the Registrant, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000899243-23-012541 · doc4.xml · nonDerivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,621

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000899243-23-009799 · doc4.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,308

SEC source: 0000899243-23-006298 · doc4.xml · derivative · entry 2

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,419

Underlying: Common Stock · 16,419 shares

Expires 2033-02-23

F2 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from February 23, 2023, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after February 23, 2023 and the remaining stock options vesting in 42 equal monthly installments thereafter.

SEC source: 0000899243-23-006298 · doc4.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,142

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three equal annual installments on February 15, 2024; February 15, 2025; and February 15, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

SEC source: 0000899243-23-006297 · doc4.xml · derivative · entry 2

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,628

Underlying: Common Stock · 24,628 shares

Expires 2033-02-23

F2 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from February 23, 2023, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after February 23, 2023 and the remaining stock options vesting in 42 equal monthly installments thereafter.

SEC source: 0000899243-23-006297 · doc4.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 98,748

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three equal annual installments on February 15, 2024; February 15, 2025; and February 15, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

SEC source: 0000899243-23-006296 · doc4.xml · derivative · entry 2

Reardon Andrew · CIK 0001950232 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,393

Underlying: Common Stock · 15,393 shares

Expires 2033-02-23

F2 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from February 23, 2023, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after February 23, 2023 and the remaining stock options vesting in 42 equal monthly installments thereafter.

SEC source: 0000899243-23-006296 · doc4.xml · nonDerivative · entry 1

Reardon Andrew · CIK 0001950232 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,608

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three equal annual installments on February 15, 2024; February 15, 2025; and February 15, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

SEC source: 0000899243-23-006294 · doc4.xml · derivative · entry 2

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,178

Underlying: Common Stock · 46,178 shares

Expires 2033-02-23

F2 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from February 23, 2023, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after February 23, 2023 and the remaining stock options vesting in 42 equal monthly installments thereafter.

SEC source: 0000899243-23-006294 · doc4.xml · nonDerivative · entry 1

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,791

F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest over three years, in three equal annual installments on February 15, 2024; February 15, 2025; and February 15, 2026, subject to the Reporting Person's continued service to the Issuer through each such vesting date.

SEC source: 0000899243-23-005552 · doc4.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,679

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

SEC source: 0000899243-23-005547 · doc4.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,096

F1 · shares: Represents shares withheld by the Issuer in payment of the tax liability arising in connection with the settlement of restricted stock units.

SEC source: 0000899243-23-000648 · doc4.xml · nonDerivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,945

F1 · kind: Shares acquired under Ligand's employee stock purchase plan. Voluntary reporting exemption under Rule 16b-3(c).

SEC source: 0000899243-22-039583 · doc4.xml · nonDerivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,569

SEC source: 0000899243-22-039580 · doc4.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,695

SEC source: 0000899243-22-039415 · doc4.xml · derivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,932

Underlying: Common Stock · 92,932 shares

Expires 2024-12-05

F1 · derivative.exercise_date: Grant to reporting person of stock options that were vested and exercisable upon grant.

SEC source: 0000899243-22-039412 · doc4.xml · derivative · entry 1

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,967

Underlying: Common Stock · 25,967 shares

Expires 2032-12-22

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from the date of grant, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after the date of grant and the remaining stock options vesting in 42 equal monthly installments thereafter.

SEC source: 0000899243-22-039410 · doc4.xml · derivative · entry 1

KOZARICH JOHN W · CIK 0001223000 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,623

Underlying: Common Stock · 6,623 shares

Expires 2032-12-22

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.

SEC source: 0000899243-22-039409 · doc4.xml · derivative · entry 1

Gray Nancy Ryan · CIK 0001714949 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,050

Underlying: Common Stock · 3,050 shares

Expires 2032-12-22

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.

SEC source: 0000899243-22-039408 · doc4.xml · derivative · entry 1

Sabba Stephen L · CIK 0001442372 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,623

Underlying: Common Stock · 6,623 shares

Expires 2032-12-22

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.

SEC source: 0000899243-22-039404 · doc4.xml · derivative · entry 1

LAMATTINA JOHN L · CIK 0001216074 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,484

Underlying: Common Stock · 4,484 shares

Expires 2032-12-22

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.

SEC source: 0000899243-22-039401 · doc4.xml · derivative · entry 1

Aryeh Jason · CIK 0001376960 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,484

Underlying: Common Stock · 4,484 shares

Expires 2032-12-22

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable on December 22, 2023.

SEC source: 0000899243-22-039399 · doc4.xml · derivative · entry 1

Davis Todd C · CIK 0001392029 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,081

Underlying: Common Stock · 2,081 shares

Expires 2032-12-22

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from the date of grant, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after the date of grant and the remaining stock options vesting in 42 equal monthly installments thereafter.

SEC source: 0000899243-22-039398 · doc4.xml · derivative · entry 1

Espinoza Octavio · CIK 0001905248 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,620

Underlying: Common Stock · 6,620 shares

Expires 2032-12-22

F1 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from the date of grant, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after the date of grant and the remaining stock options vesting in 42 equal monthly installments thereafter.

SEC source: 0000899243-22-039130 · doc4.xml · nonDerivative · entry 1

HIGGINS JOHN L · CIK 0001208906 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 422,984

F1 · kind: The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on September 22, 2022, in accordance with Rule 10b5-1.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.08 to $63.055. The reporting person undertakes to provide, upon request to the Securities Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

SEC source: 0000899243-22-038699 · doc4.xml · derivative · entry 2

Korenberg Matthew E · CIK 0001649903 · President & COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2032-12-13

F2 · derivative.exercise_date: Grant to reporting person of stock options that will vest and become exercisable over a 4-year period measured from December 5, 2022, with 12-1/2% of the shares subject to the stock options vesting on the date that is six months after December 5, 2022 and the remaining stock options vesting in 42 equal monthly installments thereafter.